##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 132 Download : 87

##plugins.themes.academic_pro.article.main##

Abstract

A cross-sectional study was conducted at different hospitals in Iraq to find out health outcomes in patients with rheumatoid arthritis in pregnant women In this study, 170 patients were collected and divided into two groups (90 patients diagnosed with pregnancy and rheumatoid arthritis) (observing 80 patients diagnosed with pregnancy and without rheumatoid arthritis or mild activity to the disease) with a period from 1 Nov 2019 to Aug 2020 Rheumatoid arthritis (RA) is a type of arthritis that mainly affects the joints, which means that the immune system does not work as well as it should, causing inflammation in the joints. Symptoms may include swelling, stiffness, discomfort, and pain and may cause restricted movement The statistical analysis program IBM SPSS SOFT 25.0 was used, where the statistical values and relationships between the patient group and the disease activity were presented, in addition to Evaluate the final outcomes for the patients of this study in terms of complications and antepartum outcomes, Intrapartum outcomes, and Postpartum outcomes

Keywords

Pregnancy Autoimmune Rheumatoid arthritis CRP

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dr. Arjan Mohammed Rasheed, Dr. Nidaa Abdulhusein Abdulhasan Alaithi, Dr. Eman Salih Taha, Dr. Ali Qais Abdulkafi, & Abbas AbdulWahhab Jumaah. (2022). Health outcomes in patients with rheumatoid arthritis in pregnant women. Texas Journal of Medical Science, 15, 154–159. https://doi.org/10.62480/tjms.2022.vol15.pp154-159
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62: 2569–2581.
  2. Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012;18: S295–S302.
  3. Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil. 2014;95 (5): 986–995.
  4. Crane MM, Juneja M, Allen J, et al. Epidemiology and treatment of new-onset and established rheumatoid arthritis in an insured US population. Arthritis Care Res. 2015; 67:1646–1655.
  5. anhidy F, Urban R, et al. Birth outcomes of children born to women with rheumatoid arthritis. Cent Eur J Public Health. 2015; 23:128–134.
  6. Barnabe C, Faris PD, Quan H. Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol. 2011; 2011:1-6.
  7. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006; 54:899–907.
  8. Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J. 2006; 10:361–366.
  9. Agency for Health Care Research and Quality. Healthcare Cost and Utilization Project (HCUP) Rockville (MD): Publishing with HCUP data; 2017.
  10. Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44-8.
  11. Van der Horst-Bruinsma IE, de Vries RR, de Buck PD, van Schendel PW, Breedveld FC, Schreuder GM, et al. Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother. Ann Rheum Dis 1998; 57:286-90.
  12. Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329:466-71.
  13. Zrour SH, Boumiza R, Sakly N, Mannai R, Korbaa W, Younes M, et al. The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity. Joint Bone Spine 2010; 77:36-40.
  14. Ostensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 1983; 26:1155-9.
  15. de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide perspective study. Arthritis Rheum 2008; 59:1241-8.
  16. Nelson JL, Ostensen M. Pregnancy, and rheumatoid arthritis. Rheum Dis Clin North Am 1997; 23:195-212.
  17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised the criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
  18. Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 2015; 74:1836-41.
  19. De Man YA, Hazes JM, van der Heide H, Willemsen SP, de Groot CJ, Steegers EA, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum 2009; 60:3196-206.
  20. de Man YA, Hazes JM, van de Geijn FE, Krommenhoek C, Dolhain RJ. Measuring disease activity and functionality during pregnancy.

Most read articles by the same author(s)